Your browser doesn't support javascript.
loading
A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort study.
Xhaard, Aliénor; Xhaard, Constance; Rubio, Marie-Therese; Berceanu, Ana; Botella-Garcia, Carmen; Coman, Tereza; Tavernier, Emmanuelle; Labussière-Wallet, Hélène; Chevallier, Patrice; Legrand, Faezeh; Thiebaut, Anne; Menard, Anne-Lise; Paillard, Catherine; Chantepie, Sylvain; Robin, Marie; Nguyen, Stephanie.
Afiliação
  • Xhaard A; Service d'hématologie-Greffe, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Paris, France.
  • Xhaard C; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM 1116, CHRU de Nancy, FCRIN INI-CRCT, Université de Lorraine, Nancy, France.
  • Rubio MT; Service d'hématologie, Hôpital Brabois, CHRU Nancy et CNRS UMR 7563, Biopôle de l'Université de Lorraine, Vandoeuvre les Nancy, France.
  • Berceanu A; Service d'hématologie, CHU Jean Minjoz, Besançon, France.
  • Botella-Garcia C; Service d'hématologie, CHU Bordeaux, Bordeaux, France.
  • Coman T; Service d'hématologie, Institut Gustave Roussy, Villejuif, France.
  • Tavernier E; Département d'hématologie Clinique et de Thérapie Cellulaire, CHU Saint-Etienne, Saint-Etienne, France.
  • Labussière-Wallet H; Service d'hématologie, Hôpital Lyon Sud, Pierre Bénite Cedex, France.
  • Chevallier P; Service d'hématologie, CHU, Nantes, France.
  • Legrand F; Département d'hématologie, Institut Paoli-Calmettes, Marseille, France.
  • Thiebaut A; Service d'hématologie, CHU Grenoble, Grenoble, France.
  • Menard AL; Service d'hématologie, CHU Rouen, Rouen, France.
  • Paillard C; Service d'hématologie pédiatrique, CHRU Strasbourg, Strasbourg, France.
  • Chantepie S; Service d'hématologie, CHU Caen, Caen, France.
  • Robin M; Service d'hématologie-Greffe, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Paris, France.
  • Nguyen S; Service d'hématologie Sorbonne Université, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Br J Haematol ; 201(6): 1066-1071, 2023 06.
Article em En | MEDLINE | ID: mdl-36921963
ABSTRACT
This 16-month-long multicentre retrospective study of 225 allogeneic haematopoietic stem cell transplantation (alloHSCT) recipients with COVID-19 examines risk factors for severity and mortality, describing the successive waves of infections (from March to June 2020 and from August 2020 to June 2021). We confirm the negative role of low respiratory tract disease and immunosuppressive treatment. We highlight significantly lower percentages of severe forms and COVID-19-related mortality during the second wave. Monthly comparative evolution of cases in alloHSCT recipients and in the French population shows a higher number of cases in alloHSCT recipients during the first wave and a decrease from February 2021.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França